Globes, 4/6/2013 - FDA suspends Pluristem stem cell study
The clinical hold was place after a patient suffered a serious allergic reaction which required hospitalization. More Info

Globes, 4/6/2013 - Evogene plans NYSE offering
The Israeli agritech company, in which Monsanto holds a stake, says it has hired US investment banks. More Info

Haaretz Business, 2/6/2013 - Kamada raises $51.6 million in Nasdaq IPO
More Info

Haaretz Business, 30/5/2013 - Israeli pharma giant Teva will make NIS 336 million tax payment and free up 'trapped profits'
More Info

Globes, 29/5/2013 - Delek Group improves gross
First quarter revenue was flat, but the group's gross profit rose 21%. More Info

Globes, 29/5/2013 - Regulator permits banks to join on IDB settlement
Antitrust Authority director general David Gilo has allowed Discount Bank to meet IDB Development's other creditor banks. More Info

Globes, 29/5/2013 - Evogene in Chinese rice enhancement collaboration
Evogene and DBN will develop increased fertilizer uptake and drought tolerance in rice, based on candidate genes discovered by Evogene. More Info

Globes, 28/5/2013 - Gazit-Globe profit swells to NIS 345m
Rental income rose 6% to NIS 1.34 billion for the first quarter. More Info

Haaretz Business, 28/5/2013 - Profits surge for Israeli food firm Strauss
More Info

Globes, 26/5/2013 - Osem sales fall but profit up
First quarter revenue fell to NIS 1.01 billion, but net profit edged up to NIS 94.6 million. More Info

Jerusalem Post, 25/5/2013 - Nochi Dankner set to lose control of IDB
IDB bondholders reach agreement that may oust Dankner from controlling the Israeli conglomerate, which controls companies such as Cellcom, Shufersal. More Info

Jerusalem Post, 24/5/2013 - Nochi Dankner set to lose control of IDB
Bondholders reach deal, may oust Dankner from conglomerate that controls companies such as Cellcom, Shufersal. More Info

Haaretz Business, 24/5/2013 - Is Israeli pharma giant Teva going to be pushed off its perch?
More Info

Globes, 22/5/2013 - Kamada to raise $69m on Nasdaq next week
The capital that Kamada plans to raise will be at a company value roughly equal to its current market cap of $331 million on the TASE. More Info

Seeking Alpha, 22/5/2013 - Partner Communications Company's CEO Discusses Q1 2013 Results - Earnings Call Transcript
More Info

Globes, 22/5/2013 - Partner profit plunges 79%
Partner CEO Haim Romano: Results reflect the continuing impact of fierce competition as reflected in significant price erosion. More Info

Seeking Alpha, 20/5/2013 - A Broad Look At Teva's Pipeline
More Info

Haaretz Business, 19/5/2013 - Market Report / Tech stocks, Teva boost TASE
More Info

Globes, 19/5/2013 - Teva CFO: I hope we can move more activities to Israel
"We'll have to examine the new tax environment." More Info

Haaretz Business, 17/5/2013 - Market Report / Technology shares, Teva pull TASE higher
More Info

Globes, 16/5/2013 - Cellcom, Partner to buy TV channels from Yes, Hot
Communications Minister Gilad Erdan and the Finance Ministry have passed a series of telecommunications reforms in the Economic Arrangements bill, including in multichannel television. More Info

Globes, 16/5/2013 - Harel, partners buy 2 Frankfurt office buildings for €98m
The buyers will provide €31.5 million in equity, and the closing is subject to securing financing from a German financial institution. More Info

Jerusalem Post, 15/5/2013 - Gas presence found in new Karish reservoir
Delek Group reports signs of significant gas presence from the Karish 1 well; Energy Minister Shalom praises announcement. More Info

Globes, 13/5/2013 - Cellcom first quarter profit down 61%
The mobile carrier missed the analysts' revenue and earnings per share consensus. More Info

Globes, 13/5/2013 - Teva mulling acquisition in South Africa - report
"Business Report": Adcock Ingram, South Africa's largest pharmaceutical company, has received acquisition offers. More Info

Seeking Alpha, 13/5/2013 - Teva: An Ideal Long-Term Pharma Stock
More Info

Globes, 12/5/2013 - "I hope we can move more activities to Israel"
Teva CFO Eyal Desheh: We'll have to examine the new tax environment. More Info

Globes, 12/5/2013 - Lapid meets Teva CEO on tax breaks
"The time has come to change the rules of the game on tax benefits." More Info

Haaretz Business, 12/5/2013 - Lapid tells Teva CEO that the drug maker must pay more taxes
More Info

Globes, 9/5/2013 - Discount Bank CEO: We must streamline
Reuven Spiegel told striking workers: The bank cannot increase its salary cost disproportionately to the bank's income. More Info